However, the mutation driven WTX silencing is rare and diverse in hepatoblastoma and CRC patients10–13, it suggests that there might be some other mechanisms responsible for WTX gene silencing and loss in those patients. The gene discussed is AMER1; the disease is hepatoblastoma.